Physician profile
Jeffrey A Abrams
NPI 1174582076
$2,154.17
in general payments reported to CMS, 2019-2025
17 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $768 · 2020: $45.88 · 2021: $199 · 2022: $498 · 2023: $363 · 2024: $97.90 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $660.33 | 2019-2025 | Skyrizi, Rinvoq, Viberzi |
| Depuy Synthes Products, INC. | $585.00 | 2019 | |
| Heartflow, INC. | $204.19 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $183.22 | 2020-2022 | |
| Celgene Corporation | $149.41 | 2021-2024 | Zeposia |
| Laborie Medical Technologies Corp. | $64.54 | 2023 | |
| Pfizer INC. | $54.96 | 2019-2025 | |
| Aimmune Therapeutics, INC. | $52.88 | 2024-2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $50.77 | 2021-2023 | |
| Janssen Biotech, INC. | $28.31 | 2019-2020 | |
| Allergan, INC. | $26.85 | 2019 | |
| Novo Nordisk INC | $23.36 | 2025 | Wegovy |
| Romark Laboratories, Lc | $17.56 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.67 | 2019 | |
| Merck Sharp & Dohme LLC | $14.47 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $12.06 | 2025 | Voquezna |
| Qol Medical, LLC | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Abrams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.